| Literature DB >> 31857126 |
Renata de Souza Sampaio1, Emmily Petícia do Nascimento2, Irwin Rose Alencar de Menezes3, Valterlúcio Dos Santos Sales4, Anita Oliveira Brito Pereira5, Giovana Mendes de Lacerda6, Enaide Soares Santos7, Maria Janice Pereira Lopes7, Luanna Gomes da Silva7, Gyllyandeson de Araújo Delmondes8, Nélio Barreto Vieira9, Victor Mantoani Zaia9, Daniel Souza Bezerra7, José Galberto Martins da Costa7, Cícero Francisco Bezerra Felipe10, Marta Regina Kerntopf11.
Abstract
Chronic pain management has several adverse effects and research looking for new and effective pain management drugs posing lower undesirable effects is necessary. Given the above, the pharmacological investigation of medicinal plants significantly contributes to the dissemination of plant-derived therapeutics. The aim of this study was to evaluate the antinociceptive activity of the Psidium brownianum Mart ex DC. leaf essential oil (PBEO) and the participation of the opioid pathway in this effect in mice. Swiss Mus musculus male mice were tested using acute nociception models (acetic acid induced abdominal contortions, formalin, capsaicin and hot plate tests). The possible myorelaxant action of the PBEO was tested using the rotarod test. The essential oil reduced animal nociception in chemical and heat models, with this action being devoid of a myorelaxant effect. Naloxone (2 mg/kg, intraperitoneally - i.p.) partially antagonized the PBEO activity, possibly acting via opioid receptors. The results obtained provide evidence that the traditional Psidium brownianum use may be effective for pain treatment.Entities:
Keywords: Antinociceptive activity; Essential oil; Natural products; Psidium brownianum
Mesh:
Substances:
Year: 2019 PMID: 31857126 DOI: 10.1016/j.fct.2019.111053
Source DB: PubMed Journal: Food Chem Toxicol ISSN: 0278-6915 Impact factor: 6.023